News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
868,643 Results
Type
Article (87850)
Company Profile (824)
Press Release (779955)
Multimedia
Podcasts (190)
Webinars (28)
Section
Business (233202)
Career Advice (4144)
Deals (39858)
Drug Delivery (145)
Drug Development (91390)
Employer Resources (203)
FDA (18372)
Job Trends (17416)
News (397800)
Policy (39955)
Tag
Academia (3006)
Academic (2)
Accelerated approval (31)
Adcomms (36)
Allergies (142)
Alliances (56981)
ALS (179)
Alzheimer's disease (1776)
Antibody-drug conjugate (ADC) (325)
Approvals (18530)
Artificial intelligence (602)
Autoimmune disease (148)
Automation (34)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (198)
Biotechnology (488)
Bladder cancer (156)
Brain cancer (63)
Breast cancer (638)
Cancer (4859)
Cardiovascular disease (427)
Career advice (3566)
Career pathing (40)
CAR-T (299)
CDC (59)
Celiac Disease (1)
Cell therapy (806)
Cervical cancer (37)
Clinical research (76821)
Collaboration (1703)
Company closure (5)
Compensation (1111)
Complete response letters (69)
COVID-19 (2984)
CRISPR (95)
C-suite (808)
Cystic fibrosis (152)
Data (6083)
Decentralized trials (2)
Denatured (70)
Depression (139)
Diabetes (518)
Diagnostics (7199)
Digital health (44)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (292)
Drug pricing (214)
Drug shortages (36)
Duchenne muscular dystrophy (231)
Earnings (99957)
Editorial (60)
Employer branding (25)
Employer resources (173)
Events (134878)
Executive appointments (1019)
FDA (21395)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (7)
Frontotemporal dementia (24)
Funding (1505)
Gene editing (206)
Generative AI (62)
Gene therapy (650)
GLP-1 (1103)
Government (5431)
Grass and pollen (8)
Guidances (381)
Healthcare (20941)
HIV (57)
Huntington's disease (48)
IgA nephropathy (85)
Immunology and inflammation (284)
Immuno-oncology (47)
Indications (80)
Infectious disease (3264)
Inflammatory bowel disease (200)
Inflation Reduction Act (17)
Influenza (116)
Intellectual property (232)
Interviews (816)
IPO (17949)
IRA (60)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (89)
Layoffs (656)
Leadership (39)
Legal (10156)
Liver cancer (97)
Longevity (14)
Lung cancer (663)
Lymphoma (368)
Machine learning (42)
Management (66)
Manufacturing (796)
MASH (171)
Medical device (14996)
Medtech (15040)
Mergers & acquisitions (22932)
Metabolic disorders (1348)
Multiple sclerosis (157)
NASH (23)
Neurodegenerative disease (335)
Neuropsychiatric disorders (92)
Neuroscience (3044)
NextGen: Class of 2026 (7706)
Non-profit (5107)
Now hiring (62)
Obesity (648)
Opinion (329)
Ovarian cancer (160)
Pain (196)
Pancreatic cancer (220)
Parkinson's disease (287)
Partnered (38)
Patents (486)
Patient recruitment (446)
Peanut (60)
People (66773)
Pharmaceutical (145)
Pharmacy benefit managers (31)
Phase I (23736)
Phase II (33329)
Phase III (25133)
Pipeline (4455)
Policy (326)
Postmarket research (3554)
Preclinical (10678)
Press Release (72)
Prostate cancer (237)
Psychedelics (53)
Radiopharmaceuticals (295)
Rare diseases (845)
Real estate (7437)
Recruiting (80)
Regulatory (28791)
Reports (65)
Research institute (2719)
Resumes & cover letters (651)
Rett syndrome (26)
RNA editing (17)
RSV (82)
Schizophrenia (157)
Series A (252)
Series B (186)
Service/supplier (30)
Sickle cell disease (102)
Special edition (27)
Spinal muscular atrophy (174)
Sponsored (47)
Startups (4331)
State (2)
Stomach cancer (20)
Supply chain (110)
Tariffs (97)
The Weekly (118)
Vaccines (1122)
Venture capital (90)
Weight loss (447)
Women's health (82)
Worklife (21)
Date
Today (158)
Last 7 days (918)
Last 30 days (2091)
Last 365 days (33311)
2026 (954)
2025 (33228)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1289)
Alabama (87)
Alaska (7)
Arizona (336)
Arkansas (14)
Asia (51452)
Australia (9031)
California (11178)
Canada (3237)
China (1111)
Colorado (468)
Connecticut (488)
Delaware (338)
Europe (118227)
Florida (1635)
Georgia (356)
Hawaii (3)
Idaho (68)
Illinois (928)
India (64)
Indiana (530)
Iowa (23)
Japan (408)
Kansas (131)
Kentucky (42)
Louisiana (29)
Maine (82)
Maryland (1428)
Massachusetts (8291)
Michigan (348)
Minnesota (643)
Mississippi (6)
Missouri (136)
Montana (35)
Nebraska (28)
Nevada (121)
New Hampshire (83)
New Jersey (3041)
New Mexico (33)
New York (2971)
North Carolina (1570)
North Dakota (10)
Northern California (5313)
Ohio (342)
Oklahoma (22)
Oregon (54)
Pennsylvania (2247)
Puerto Rico (20)
Rhode Island (49)
South America (1656)
South Carolina (62)
South Dakota (1)
Southern California (4300)
Tennessee (172)
Texas (1769)
United States (40549)
Utah (335)
Vermont (1)
Virginia (280)
Washington D.C. (85)
Washington State (942)
West Virginia (4)
Wisconsin (122)
Wyoming (2)
There are 868,643 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Biolexis Therapeutics to Present at J.P. Morgan Healthcare Conference
Company to Highlight the complete solution to the GLP-1 weight regain crisis: Only All-Oral Dual-Mechanism Metabolic Platform in Clinical Development, Featuring First-in-Class Oral GLP-1 Agonist and Muscle-Selective AMPK Activator
January 9, 2026
·
1 min read
Earnings
Insmed Jumps on ‘Blowout’ Sales Beat for Bronchiectasis Drug Brinsupri
Insmed’s freshly approved lung condition drug soared past sales expectations for 2025, netting $144.6 million in its first full quarter of sales.
January 9, 2026
·
1 min read
·
Dan Samorodnitsky
Press Releases
Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2025 Net Revenue
January 9, 2026
·
10 min read
Press Releases
Clene Announces Registered Direct Offering of Over $28 Million
January 9, 2026
·
10 min read
Press Releases
Lexicon Pharmaceuticals Publishes “Relief is Possible: Ensuring Access to Effective Treatments for Chronic Pain”
January 9, 2026
·
3 min read
Press Releases
CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 9, 2026
·
1 min read
Press Releases
Tenaya Therapeutics Announces 2026 Strategic Priorities and Anticipated Milestones
January 9, 2026
·
11 min read
Press Releases
CG Oncology Provides Updated Timeline for PIVOT-006 Phase 3 Topline Data in Intermediate-Risk NMIBC
January 9, 2026
·
5 min read
Press Releases
Autonomix Showcases Compelling PoC Study Clinical Data Showing Rapid and Durable Pain Relief Across All Disease Stages of Pancreatic Cancer at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium
January 9, 2026
·
5 min read
Press Releases
PDS Biotech Announces FDA Alignment on use of Progression Free Survival (PFS) as Primary Endpoint
January 9, 2026
·
6 min read
1 of 86,865
Next
